Vault-13

Aquilo Capital Management, LLC

SAN FRANCISCO, CA · CIK 1591986 · 13F filing filed 2022-05-16

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$342.6m reported value -15.8% vs Q4 2021
12positions
96.0%in top 10
0 new 11 added 0 reduced 1 sold out vs Q4 2021

Options: 1 call positions ($179.8m notional), 1 put positions ($158.1m notional) – listed below, not included above.

Holdings, Q1 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 BLUEPRINT MEDICINES CORP COM BPMC BPMC 781,539 $49.9m14.57% 14.57% AddedShares held: Q2 2021 448.5k, Q3 2021 521.7k, Q4 2021 645.5k, Q1 2022 781.5k +136.0k +136,000 21.1%
2 ARROWHEAD PHARMACEUTICALS IN COM ARWR ARWR 1,047,440 $48.2m14.06% 14.06% AddedShares held: Q2 2021 432.9k, Q3 2021 527.9k, Q4 2021 700.4k, Q1 2022 1.0m +347.0k +347,014 49.5%
3 ARVINAS INC COM ARVN ARVN 695,247 $46.8m13.66% 13.66% AddedShares held: Q2 2021 0, Q3 2021 354.7k, Q4 2021 563.5k, Q1 2022 695.2k +131.8k +131,796 23.4%
4 SPERO THERAPEUTICS INC COM SPRO SPRO 5,281,504 $45.9m13.41% 13.41% AddedShares held: Q2 2021 3.8m, Q3 2021 4.6m, Q4 2021 5.0m, Q1 2022 5.3m +317.3k +317,323 6.4%
5 REGENXBIO INC COM RGNX RGNX 1,118,684 $37.1m10.84% 10.84% AddedShares held: Q2 2021 595.4k, Q3 2021 839.1k, Q4 2021 1.0m, Q1 2022 1.1m +105.1k +105,088 10.4%
6 MERUS N V COM MRUS MRUS 1,261,534 $33.4m9.74% 9.74% AddedShares held: Q2 2021 0, Q3 2021 0, Q4 2021 896.5k, Q1 2022 1.3m +365.0k +365,032 40.7%
7 4D MOLECULAR THERAPEUTICS IN COM FDMT FDMT 1,755,506 $26.5m7.75% 7.75% AddedShares held: Q2 2021 945.4k, Q3 2021 1.1m, Q4 2021 1.5m, Q1 2022 1.8m +245.6k +245,562 16.3%
8 UNIQURE NV SHS QURE QURE 901,490 $16.3m4.76% 4.76% AddedShares held: Q2 2021 1.2m, Q3 2021 1.3m, Q4 2021 676.2k, Q1 2022 901.5k +225.3k +225,284 33.3%
9 AMRYT PHARMA PLC SPONSORED ADS SPONSORED ADS 1,640,000 $13.6m3.96% 3.96% UnchangedShares held: Q2 2021 1.1m, Q3 2021 1.4m, Q4 2021 1.6m, Q1 2022 1.6m
10 PIERIS PHARMACEUTICALS INC COM COM 3,708,882 $11.2m3.28% 3.28% AddedShares held: Q2 2021 3.2m, Q3 2021 3.2m, Q4 2021 3.2m, Q1 2022 3.7m +512.4k +512,355 16.0%
11 ARGENX SE SPONSORED ADR ARGX ARGX 24,000 $7.6m2.21% 2.21% AddedShares held: Q2 2021 21.2k, Q3 2021 22.2k, Q4 2021 22.2k, Q1 2022 24.0k +1.8k +1,800 8.1%
12 GENMAB A/S SPONSORED ADS GMAB GMAB 167,500 $6.1m1.77% 1.77% AddedShares held: Q2 2021 120.0k, Q3 2021 127.5k, Q4 2021 127.5k, Q1 2022 167.5k +40.0k +40,000 31.4%

Sold out since Q4 2021

SecurityTickerShares held beforeValue then
MAGENTA THERAPEUTICS INC 3,155,082 $14.0m3.2m shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
SPDR SER TR XBI · Call XBICall 2,000,000 $179.8m2.0m shares New
SPDR S&P 500 ETF TR SPY · Put SPYPut 350,000 $158.1m350.0k shares Reduced

Trades reported as a company insider in Q1 2022

Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.

DateCompanyTickerTradeShares ValueTheir holding
2022-03-30 SPERO THERAPEUTICS INC 10% owner · See Footnotes SPRO Bought 50,000 $439.5k50.0k shares +1%
2022-03-14 SPERO THERAPEUTICS INC 10% owner · See footnotes SPRO Bought 15,702 $119.8k15.7k shares +<1%
2022-03-14 SPERO THERAPEUTICS INC 10% owner · See Footnotes SPRO Bought 8,006 $61.1k8.0k shares +<1%
2022-02-28 SPERO THERAPEUTICS INC 10% owner · See Footnotes SPRO Bought 44,833 $427.3k44.8k shares +1%
2022-02-18 SPERO THERAPEUTICS INC 10% owner · See Footnotes SPRO Bought 14,828 $137.0k14.8k shares +<1%
2022-01-31 SPERO THERAPEUTICS INC 10% owner · See Footnotes SPRO Bought 125,000 $1.4m125.0k shares +2%
2022-01-24 SPERO THERAPEUTICS INC 10% owner · See Footnotes SPRO Bought 1,599 $17.4k1.6k shares +<1%
2022-01-18 SPERO THERAPEUTICS INC 10% owner · See Footnotes SPRO Bought 48,488 $601.7k48.5k shares +1%
2022-01-10 SPERO THERAPEUTICS INC 10% owner · See Footnotes SPRO Bought 8,867 $114.7k8.9k shares +<1%